Cypress Capital Group Laboratory Corp Of America Holdings Transaction History

Cypress Capital Group

$879 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$197.69 - $227.29 $14,826 - $17,046	-75 Reduced 7.44%	933 $212,000
Q1 2023 May 04, 2023	SELL	$213.32 - $257.83 $789,284 - $953,970	-3,700 Reduced 78.59%	1,008 $231,000
Q4 2022 Feb 14, 2023	SELL	$203.72 - $248.97 $128,343 - $156,851	-630 Reduced 11.8%	4,708 $1.11 Million
Q3 2022 Nov 04, 2022	SELL	$204.81 - $262.19 $150,125 - $192,185	-733 Reduced 12.07%	5,338 $1.09 Million
Q2 2022 Jul 26, 2022	SELL	$213.86 - $277.87 $8,768 - $11,392	-41 Reduced 0.67%	6,071 $1.42 Million
Q1 2022 May 16, 2022	BUY	$259.82 - $298.18 $930,935 - $1.07 Million	3,583 Added 141.68%	6,112 $1.61 Million
Q4 2021 Feb 15, 2022	SELL	$271.6 - $314.21 $250,686 - $290,015	-923 Reduced 26.74%	2,529 $794,000
Q3 2021 Oct 12, 2021	BUY	$274.82 - $308.34 $229,749 - $257,772	836 Added 31.96%	3,452 $972,000
Q2 2021 Jul 13, 2021	BUY	$251.87 - $278.14 $142,054 - $156,870	564 Added 27.49%	2,616 $722,000
Q1 2021 Apr 14, 2021	SELL	$204.88 - $255.03 $180,704 - $224,936	-882 Reduced 30.06%	2,052 $523,000
Q4 2020 Jan 12, 2021	SELL	$186.91 - $214.42 $271,580 - $311,552	-1,453 Reduced 33.12%	2,934 $597,000
Q3 2020 Oct 08, 2020	BUY	$167.03 - $201.3 $148,322 - $178,754	888 Added 25.38%	4,387 $826,000
Q2 2020 Jul 10, 2020	BUY	$113.31 - $182.44 $172,117 - $277,126	1,519 Added 76.72%	3,499 $581,000
Q1 2020 Apr 08, 2020	SELL	$104.32 - $195.28 $20,342 - $38,079	-195 Reduced 8.97%	1,980 $250,000
Q4 2019 Jan 10, 2020	SELL	$163.48 - $173.61 $76,835 - $81,596	-470 Reduced 17.77%	2,175 $368,000
Q3 2019 Oct 10, 2019	SELL	$159.77 - $178.1 $105,448 - $117,546	-660 Reduced 19.97%	2,645 $444,000
Q2 2019 Aug 15, 2019	SELL	$144.16 - $172.9 $65,448 - $78,496	-454 Reduced 12.08%	3,305 $571,000
Q1 2019 May 14, 2019	BUY	$123.7 - $156.3 $24,121 - $30,478	195 Added 5.47%	3,759 $575,000
Q4 2018 Feb 19, 2019	SELL	$120.82 - $174.09 $1.13 Million - $1.63 Million	-9,379 Reduced 72.46%	3,564 $450,000
Q3 2018 Nov 15, 2018	SELL	$167.67 - $188.27 $244,798 - $274,874	-1,460 Reduced 10.14%	12,943 $2.25 Million
Q2 2018 Aug 15, 2018	BUY	$160.33 - $189.41 $472,492 - $558,191	2,947 Added 25.72%	14,403 $2.59 Million
Q1 2018 May 21, 2018	BUY	$161.53 - $178.11 $627,544 - $691,957	3,885 Added 51.31%	11,456 $1.85 Million
Q4 2017 Feb 14, 2018	BUY	$147.99 - $163.95 $325,578 - $360,690	2,200 Added 40.96%	7,571 $1.21 Million
Q3 2017 Nov 16, 2017	BUY	$149.47 - $160.56 $354,393 - $380,687	2,371 Added 79.03%	5,371 $811,000
Q2 2017 Aug 15, 2017	BUY	N/A	3,000	3,000 $462,000

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Group with notifications on news.

Account